Showing 34,794 results

Filters
Hepatitis C treatment

Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study

News
30 October 2015
Hepatitis C treatment

Hepatitis C: behind new wonder drugs lies a terrible dilemma

Editor's pick
The Conversaion
29 October 2015
Hepatitis C treatment

Report: Hepatitis C in Eastern Europe and Central Asia: Civil society response to the epidemic

Editor's pick
International HIV/AIDS Alliance Ukraine
29 October 2015
Pharmaceutical industry

Why are HIV meds so expensive, and what can we do about it?

Editor's pick
BETA blog
29 October 2015
Hepatitis C transmission & prevention

New research traces hepatitis C infections in Scotland back to WWII

Editor's pick
Medical Xpress
28 October 2015
Pharmaceutical industry

GlaxoSmithKline beats sales forecasts thanks to HIV drugs boost

Editor's pick
The Guardian
28 October 2015
Tuberculosis & HIV

TAG Response to the Release of the World Health Organization’s 2015 Global Tuberculosis Report

Editor's pick
Treatment Action Group
28 October 2015
Tuberculosis & HIV

Tuberculosis now rivals AIDS as leading cause of death: WHO

Editor's pick
Reuters
28 October 2015
Drug-resistant TB

Bulk of world’s MDR-TB cases undiagnosed – WHO

Editor's pick
Health-E News
28 October 2015
Government, leadership & policy

Canada: Change was promised - time to deliver

Editor's pick
Positive Lite
28 October 2015
Money

Nearly three-quarters of providers offer HIV cover

Editor's pick
FT Adviser
28 October 2015
Hepatitis & HIV

Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection

News
28 October 2015
Retention & linkage to care

Better Organized HIV Care Could Save Lives and Billions of Dollars, Computer Model Predicts

Editor's pick
Johns Hopkins Medicine
28 October 2015
Hepatitis C transmission & prevention

Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs

News
28 October 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial

News
28 October 2015
Pharmaceutical industry

Gilead hepatitis C drug sales trend flattens, shares dip

Editor's pick
Reuters
28 October 2015
Migrants, refugees & displaced people

Many Countries Deny Antiretrovirals to Undocumented Migrants

Editor's pick
Medscape
28 October 2015
Neurological & cognitive problems

START sub-studies show no differences in lung or neurocognitive function with early or later treatment

News
27 October 2015
Bone & joint problems

START sub-study shows more bone loss with earlier HIV treatment

News
27 October 2015
Harm reduction

Community-based drug projects provide an alternative to compulsory detention in Asia

News
27 October 2015
Chemsex & recreational drug use

London clinic survey shows impact of chemsex on condom and PEP use

News
27 October 2015
Cardiovascular disease

Risk of heart attack rises with length of HIV infection, regardless of age

News
27 October 2015
Hepatitis C treatment

New Yorkers on pace to spend $1 B. on Hepatitis C cures

Editor's pick
Capital New York
27 October 2015
Access to healthcare

South Africa should override patent on key HIV medicine after widespread stock out problem

Editor's pick
MSF
27 October 2015